AMIX Quote, Financials, Valuation and Earnings

Perspective Therapeutics has a net margin of -- compared to Autonomix Medical's net margin of --. Autonomix Medical's return on equity of -- beat Perspective Therapeutics's return on equity of --.

Autonomix Medical has a consensus price target of $11.50, signalling upside risk potential of 709.86%. On the other hand Perspective Therapeutics has an analysts' consensus of $14.1071 which suggests that it could grow by 261.72%. Given that Autonomix Medical has higher upside potential than Perspective Therapeutics, analysts believe Autonomix Medical is more attractive than Perspective Therapeutics.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.177, suggesting its more volatile than the S&P 500 by 17.701%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than Perspective Therapeutics quarterly revenues of --. Autonomix Medical's net income of -$3.2M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, Autonomix Medical's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 27.49x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

Integer Holdings has a net margin of -- compared to Autonomix Medical's net margin of -5.14%. Autonomix Medical's return on equity of -- beat Integer Holdings's return on equity of 4.85%.

Autonomix Medical has a consensus price target of $11.50, signalling upside risk potential of 709.86%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 24.51%. Given that Autonomix Medical has higher upside potential than Integer Holdings, analysts believe Autonomix Medical is more attractive than Integer Holdings.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.988%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than Integer Holdings quarterly revenues of $437.4M. Autonomix Medical's net income of -$3.2M is higher than Integer Holdings's net income of -$22.5M. Notably, Autonomix Medical's price-to-earnings ratio is -- while Integer Holdings's PE ratio is 56.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 2.41x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX has a net margin of -- compared to Autonomix Medical's net margin of -2201.34%. Autonomix Medical's return on equity of -- beat VolitionRX's return on equity of --.

Autonomix Medical has a consensus price target of $11.50, signalling upside risk potential of 709.86%. On the other hand VolitionRX has an analysts' consensus of $2.94 which suggests that it could grow by 329.39%. Given that Autonomix Medical has higher upside potential than VolitionRX, analysts believe Autonomix Medical is more attractive than VolitionRX.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.798%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than VolitionRX quarterly revenues of $246.4K. Autonomix Medical's net income of -$3.2M is higher than VolitionRX's net income of -$5.4M. Notably, Autonomix Medical's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 47.19x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -- compared to Autonomix Medical's net margin of 0.18%. Autonomix Medical's return on equity of -- beat Xtant Medical Holdings's return on equity of -26.62%.

Autonomix Medical has a consensus price target of $11.50, signalling upside risk potential of 709.86%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 171.99%. Given that Autonomix Medical has higher upside potential than Xtant Medical Holdings, analysts believe Autonomix Medical is more attractive than Xtant Medical Holdings.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than Xtant Medical Holdings quarterly revenues of $32.9M. Autonomix Medical's net income of -$3.2M is lower than Xtant Medical Holdings's net income of $58K. Notably, Autonomix Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 0.72x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.